TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Impaired transient receptor potential melastatin 3 (TRPM3), a phosphatidylinositol dependent channel, and impaired calcium mobilisation have been implicated in ME/CFS pathology.